Comparison of local corticosteroid vs. botulinum toxin A injection in rotator cuff tendinitis

The comparison of single session local ultrasound-guided botulinum toxin A and corticosteroid injection in rotator cuff tendinitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170910036107N6

Enrollment

Registered

2020-11-02

Start date

2020-11-03

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff tendinitis. Unspecified injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

Interventions

Intervention 1: Intervention group: ULtrasound-guided injection of 100 IU botulinum toxin A in the subacromial bursa with lateral approach. Intervention 2: Control group: Ultrasound-guided injection o

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Rotator cuff tendinitis; positive shoulder test including Neer, Hawkins or Yocum VAS>4 The willingness of patient to participate in the research project

Exclusion criteria

Exclusion criteria: History of rotator cuff tear History of diabetes mellitus, coagulation disorders, fractures, rheumatic diseases, tumors and active infections Shoulder injection in the last 3 months Intra-articular injection contraindications Corticosteroid or lidocaine injection contraindications Botulinum toxin A injection contraindications

Design outcomes

Primary

Measure	Time frame
Visual analog scale. Timepoint: Before injection, 2 weeks after injection, 2 month after injection. Method of measurement: Questionnaire.;Constant score. Timepoint: Before injection, 2 weeks after injection, 2 month after injection. Method of measurement: Constant score questionnaire.;Shoulder Pain and Disability Index. Timepoint: Before injection, 2 weeks after injection, 2 month after injection. Method of measurement: SPADI questionnaire.	—

Measure

Time frame

Visual analog scale. Timepoint: Before injection, 2 weeks after injection, 2 month after injection. Method of measurement: Questionnaire.;Constant score. Timepoint: Before injection, 2 weeks after injection, 2 month after injection. Method of measurement: Constant score questionnaire.;Shoulder Pain and Disability Index. Timepoint: Before injection, 2 weeks after injection, 2 month after injection. Method of measurement: SPADI questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNaseh Usefi

Iran University of Medical Sciences

nasehusefi@gmail.com+98 21 8214 1612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026